rss

Fauci on the news wires – sees a whole lot of pain if COVID-19 trends do not change

Dr Fauci, Director of the National Institute of Allergy and Infectious Diseases in the US, in an interview with CNBC

  • sees a whole lot of pain if covid trends don’t change
  • mask-wearing, distancing would have a big impact
  • very little appetite
  • for lockdown in US
  • changes need to be made to combat in US
  • doubtful White House will mandate national mask-wearing

Fauci says COVID-19 vaccine could be available earlier if clinical trials overwhelmingly positive

Dr. Anthony Fauci is director of the National Institute of Allergy and Infectious Diseases, interview.

  • Referring to two ongoing clinical trials of 30,000 volunteers are expected to conclude by the end of the year
Fauci said an independent board has the authority to end the trials weeks early if interim results are overwhelmingly positive or negative.

  • Data and Safety Monitoring Board could say, “‘The data is so good right now that you can say it’s safe and effective,'” Fauci said. In that case, researchers would have “a moral obligation” to end the trial early and make the active vaccine available to everyone in the study, including those who had been given placebos – and accelerate the process to give the vaccine to millions.
Here is the link to the piece for more.
Dr. Anthony Fauci is director of the National Institute of Allergy and Infectious Diseases, interview. 

Coronavirus – Fauci says an antibody could be ready by fall

Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci spoke with (wait for it)  Facebook CEO Mark Zuckerberg in a YouTube event.

Some of Fauci’s remarks (via Bloomberg):
  • COVID-19 is very different from the severity of the 1918 virus
  • Monoclonal antibody drug could be ready for use by fall
  • No signs that face masks could cause harm to people
Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci spoke with (wait for it)  Facebook CEO Mark Zuckerberg in a YouTube event.
A little more on his timing remark …
  • by mid-to-late fall, early winter, we’ll know whether we have candidates that are safe and effective, and I hope and anticipate that we will have one or more.
  • If that’s the case, by the end of this year, beginning of 2021, we may have one or more candidate that is actually safe and effective. That being the case we can start distributing doses widely at that time.
Go to top